Page 1118 - Williams Hematology ( PDFDrive )

1092 Part VIII: Monocytes and Macrophages Chapter 69: Disorders of Monocytes 1093

35. Foucar E, Rosai J, Dorfman RF: Sinus histiocytosis with massive lymphadenopathy. lymphocyte pattern in severely injured male trauma patients. Crit Care Med 31:1722,
Cancer 54:1834, 1984. 2003.
36. Pauli M, Bergamashi G, Tonon L, et al: Evidence of a polyclonal nature of the cell infil- 66. De AK, Laudanski K, Miller-Graziano CL: Failure of monocytes of trauma patients to
trate in sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). convert to immature dendritic cells is related to preferential macrophage-colony-stim-
Br J Haematol 91:415, 1995. ulating factor-driven macrophage differentiation. J Immunol 170:6355, 2003.
37. Beutler E: Gaucher disease: Multiple lessons from a single gene disorder. Acta Paediatr 67. Venet F, Tissot S, Debard AL, et al: Decreased monocyte human leukocyte antigen-DR
Suppl 95:103, 2006. expression after severe burn injury: Correlation with severity and secondary septic
38. Schuchman EH: The pathogenesis and treatment of acid sphingomyelinase-deficient shock. Crit Care Med 35:1910, 2007.
Niemann-Pick disease. J Inherit Metab Dis 30:654, 2007. 68. Pachot A, Cazalis MA, Venet F, et al: Decreased expression of the fractalkine receptor
39. Brunetti-Pierri N, Scaglia F: GM(1) gangliosidosis: Review of clinical, molecular, and CX3CR1 on circulating monocytes as new feature of sepsis-induced immunosuppres-
therapeutic aspects. Mol Genet Metab 94:391, 2008. sion. J Immunol 180:6421, 2008.
40. Hirayama Y, Kohada K, Andoh M, et al: Syndrome of the sea-blue histiocyte. Intern 69. Tsujimoto H, Ono S, Efron PA, et al: Role of Toll-like receptors in the development of
Med 35:419, 1996. sepsis. Shock 29:315, 2008.
41. Chang KL, Snyder DS: Langerhans cell histiocytosis. Cancer Treat Res 142:383, 2008. 70. Albaiceta GM, Pedreira PR, García-Prieto E, Taboada F: Therapeutic implications of
42. Bechan GI, Egeler RM, Arceci RJ: Biology of Langerhans cells and Langerhans cell his- immunoparalysis in critically ill patients. Inflamm Allergy Drug Targets 6:191, 2007.
tiocytosis. Int Rev Cytol 254:1, 2006. 71. Sica A, Schioppa T, Mantovani A, Allavena P: Tumour-associated macrophages are a
43. Jaffe ES, Harris NL, Stein H, Vardiman JW: Tumors of haematopoietic and lymphoid distinct M2 polarised population promoting tumour progression: Potential targets of
tissues. Histiocytic and dendritic cell neoplasms, in World Health Organization Classifi- anti-cancer therapy. Eur J Cancer 42:717, 2006.
cation of Tumors, pp 273–289. IARC Press, Lyon, 2001. 72. Allavena P, Sica A, Solinas G, et al: The inflammatory micro-environment in tumor
44. Lopez-Berestein G, Klostergaard J, editors: Mononuclear Phagocytes in Cell Biology. progression: The role of tumor-associated macrophages. Crit Rev Oncol Hematol 66:1,
CRC Press, Boca Raton, FL, 1993. 2008.
45. Cline MJ: Histiocytes and histiocytosis. Blood 84:2840, 1994. 73. Ryder MI, Saghizadeh M, Ding Y, et al: Effects of tobacco smoke on secretion of inter-
46. Asherson GL, Zembala M: Monocyte abnormalities in disease, in Human Monocytes, leukin 1-beta, tumor necrosis factor-alpha, and transforming growth-beta from periph-
edited by Zembala M, Asherson GL, pp 395–415. Academic Press, London, 1989. eral blood mononuclear cells. Oral Microbiol Immunol 17:331, 2002.
47. Abboud RT, Vimalanathan S: Pathogenesis of COPD. Part I. The role of protease- 74. Chen H, Cowan MJ, Hasday JD, et al: Tobacco smoking inhibits expression of proin-
antiprotease imbalance in emphysema. Int J Tuberc Lung Dis 12:361, 2008. flammatory cytokines and activation of IL-1R-associated kinase, p38, and NF-kappaB
48. Aldonyte R, Jansson L, Piitulainen E, Janciauskiene S: Circulating monocytes from in alveolar macrophages stimulated with TLR2 and TLR4 agonists. J Immunol 179:6097,
healthy individuals and COPD patients. Respir Res 4:11, 2003. 2007.
49. Kaplan J, De Domenico I, Ward DM: Chediak-Higashi syndrome. Curr Opin Hematol 75. Shay AH, Choi R, Whittaker K, et al: Impairment of antimicrobial activity and nitric
15:22, 2008. acid production by alveolar macrophages from smokers of marijuana and cocaine. J
50. Davis WC, Huber H, Douglas SD, Fudenberg HH: A defect in circulating mononuclear Infect Dis 187:700, 2003.
phagocytes in chronic granulomatous disease of childhood. J Immunol 101:1093, 1968. 76. Klein TW, Cabral GA: Cannabinoid-induced immune suppression and modulation of
51. Stasia MJ, Li XJ: Genetics and immunopathology of chronic granulomatous disease. antigen-presenting cells. J Neuroimmune Pharmacol 1:50, 2006.
Semin Immunopathol 30:209, 2008. 77. Marth T, Neurath M, Cuccherini BA, Strober W: Defects of monocyte interleukin 12
52. Orsini E, Guarini A, Chiaretti S, et al: The circulating dendritic cell compartment in production an humoral immunity in Whipple’s disease. Gastroenterology 113:442, 1997.
patients with chronic lymphocytic leukemia is severely defective and unable to stimu- 78. Desnues B, Ihrig M, Raoult D, Mege JL: Whipple’s disease: A macrophage disease. Clin
late an effective T cell response. Cancer Res 63:4497, 2003. Vaccine Immunol 13:170, 2006.
53. Mami NB, Mohty M, Aurran-Schleinitz T, et al: Blood dendritic cells in patients with 79. Moore KW, de Waal Maleyt R, Coffman RL, O’Garra A: Interleukin-10 and the interleu-
chronic lymphocytic leukaemia. Immunobiology 213:493, 2008. kin 10 receptor. Annu Rev Immunol 19:683, 2001.
54. Snyderman R, Altman LC, Frankel A, Blaese RM: Defective mononuclear leukocyte 80. Dobrovolskaia MA, Vogel SN: Toll receptors, CD14, and macrophage activation and
chemotaxis. Ann Intern Med 78:509, 1973. deactivation by LPS. Microbes Infect 4:903, 2002.
55. Komiyama A, Ichikawa M, Kanda H, et al: Defective interleukin 1 production in a 81. Tousoulis D, Davies G, Stefanadis C, et al: Inflammatory and thrombotic mechanisms
familial monocyte disorder with a combined abnormality of mobility and phagocytosis- in coronary atherosclerosis. Heart 89:993, 2003.
killing. Clin Exp Immunol 73:500, 1988. 82. Oliveira RT, Mamoni RL, Souza JR, et al: Differential expression of cytokines, chemok-
56. Bhavsar PK, Sukkar MB, Khorasani N, et al: Glucocorticoid suppression of CX3CL1 ines and chemokine receptors in patients with coronary artery disease. Int J Cardiol
(fractalkine) by reduced gene promoter recruitment of NF-kappaB. FASEB J 22:1807, 24:17, 2009.
2008. 83. Murphy AJ, Woollard KJ, Hoang A, et al: High-density lipoprotein reduces the human
57. Ehrchen J, Steinmüller L, Barczyk K, et al: Glucocorticoids induce differentiation of a monocyte inflammatory response. Arterioscler Thromb Vasc Biol 28:2071, 2008.
specifically activated, anti-inflammatory subtype of human monocytes. Blood 109:1265, 84. Jawie J: New insights into immunological aspects of atherosclerosis. Pol Arch Med
2007. Wewn 118:127, 2008.
58. Nomura I, Abe J, Noma S, et al: Adrenomedullin is highly expressed in blood mono- 85. Brambilla M, Camera M, Colnago D, et al: Tissue factor in patients with acute coronary
cytes associated with acute Kawasaki disease: A microarray gene expression study. Pediatr syndromes: Expression in platelets, leukocytes, and platelet-leukocyte aggregates.
Res 57:49, 2005. Arterioscler Thromb Vasc Biol 28:947, 2008.
59. Matsubara T, Ichiyama T, Furukawa S: Immunological profile of peripheral blood 86. Martin J, Collot-Teixeira S, McGregor L, McGregor JL: The dialogue between endothe-
lymphocytes and monocytes/macrophages in Kawasaki disease. Clin Exp Immunol lial cells and monocytes/macrophages in vascular syndromes. Curr Pharm Des 13:1751,
141:381, 2005. 2007.
60. Van Crevel R, Curfs J, van der Ven AJ et al: Functional and morphological monocyte 87. Napoleone E, di Santo A, Peri G, et al: The long pentraxin PTX3 up-regulates tissue fac-
abnormalities in a patient with malakoplakia. Am J Med 105:74, 1998. tor in activated monocytes: Another link between inflammation and clotting activation.
61. Ridgeway D, Wolff LJ, Wall M, Bouzy MS, et al: Indomethacin-sensitive monocyte kill- J Leukoc Biol 76:203, 2004.
ing defect in a child with disseminated atypical mycobacterial disease. J Clin Immunol 88. Key NS: Platelet tissue factor: How did it get there and is it important? Semin Hematol
11:357, 1991. 45(Suppl 1):S16, 2008.
62. Onwubalili JK: Defective monocyte chemotactic responsiveness in patients with active 89. Weisberg SP, McCann D, Desai M, et al: Obesity is associated with macrophage accu-
tuberculosis. Immunol Lett 16:39, 1987. mulation in adipose tissue. J Clin Invest 112:1796, 2003.
63. Welin A, Winberg ME, Abdalla H, et al: Incorporation of Mycobacterium tuberculosis 90. Giannelli S, Taddeo A, Presicce P, et al: A six-color flow cytometric assay for the analysis
lipoarabinomannan into macrophage membrane rafts is a prerequisite for the phagoso- of peripheral blood dendritic cells. Cytometry B Clin Cytom 74:349, 2008.
mal maturation block. Infect Immun 76:2882, 2008. 91. Koga Y, Matsuzaki A, Suminoe A, et al: Expression of cytokine-associated genes in den-
64. Murray RA, Siddiqui MR, Mendillo M, et al: Mycobacterium leprae inhibits dendritic dritic cells (DCs): Comparison between adult peripheral blood- and umbilical cord
cell activation and maturation. J Immunol 178:338, 2007. blood-derived DCs by cDNA microarray. Immunol Lett 116:55, 2008.
65. Spolarics Z, Siddiqi M, Siegel JH, et al: Depressed interleukin-12-producing activ- 92. Pérez-Cabezas B, Naranjo-Gómez M, Fernández MA, et al: Reduced numbers of plas-
ity by monocytes correlates with adverse clinical course and a shift toward Th2-type macytoid dendritic cells in aged blood donors. Exp Gerontol 42:1033, 2007.

Kaushansky_chapter 69_p1089-1094.indd 1093 9/18/15 9:47 AM